39 Steps
Maximum: 19.5 CME cr.
0 new discussion posts (4 published)
Sign in to view your progression
Learning objectives Learn...
Target audience Targe...
Credit designation Credi...

To update the participants on the current and future practices in transfusion medicine.

The Congress webcasts include plenary lectures and simultaneous symposia with review lectures and presentations on the most recent findings and developments in the field and basic and applied sciences.

The range of subjects comprises the whole transfusion chain from the donor to the recipient. All presentations have associated learning quizzes.

The audience profile is medical and scientific specialists from around the world, ranging from junior clinician or scientist to Professor/Head of Dept. in a clinical or Academic position.

The audience includes those working in the field of transfusion medicine from the donor to the patient and disciplines including cellular therapies and haematology.

The EBAH designates this live activity for a maximum of 19.5 credit points.

Red cell alloantibodies - clinical significance or noise
Introducing genotyping into routine practice
Solving difficult cases in autoimmune haemolytic anaemia
Managing the patient with haemoglobinopathy and multiple red cell antibodies
Understanding Thrombotic Thrombocytopenic Purpura
Neutrophil alloantigens in different populations: New aspects?
Managing bleeding emergencies
Managing the chronically transfused patient
Investigation and Management of non-infectious adverse transfusion reactions
Automation in blood processing - is it cost effective
Approaches to assessing and minimising blood wastages in the hospital and blood supply chain
The measure of blood component quality
Heme-induced toxicity in blood cells protected by heme-binding hemopexin
Translational: animal models
Complications following red blood cells transfusion - clinical hyperhaemolysis
Current methods to manufacture human platelet lysates, and possible trends in product safety and standardisation
Ex vivo culture of platelets
Big data in transfusion medicine ? towards a database driven approach to ensuring the long-term health of both blood donors and transfused patients as the best submission
Preclinical evaluation of stored blood versus fresh blood
Clinical data on age of blood
The Red Cell Storage Lesion: Of Dogs and Men
Hematological malignancies, solid cancers, and red cell alloimmunization: a case-control study
Perioperative RBC transfusions are associated with 30 day post-operative risk of venous thromboembolism: a robust prediction model from a large North American multi-center prospective registry
Management of thalassaemia
Transfusion in African children with severe anaemia
Transfusion transmission and prevention of transmission in non-endemic countries
The global epidemiology of arboviruses with focus on Zika
Emerging Arboviruses and Transfusion
Developing New Pharmacotherapeutic Approaches to Treating Sickle Cell Disease
What's new in the pathophysiology of sickle cell disease
Immune regulation of Sickle Cell Alloimmunization
In-hospital mortality of critically bleeding patients requiring massive transfusion in Australia and New Zealand
Using major haemorrhage prescriptions to improve delivery ? a 3 year audit of utilisation of a major haemorrhage protocol in a UK major trauma centre
The indonesian approach to prevent maternal mortality
State of the Art on Obstetric Transfusion Practice, The Reds Program
Cultured RBCs for Transfusion, how far are we?
Ethical aspects of medical products of human origin
Update on the study of safety and effectiveness of patient blood management in surgical patients

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies